TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the ...

Berlin, 03 February 2025. Due to an unexpected IT incident, Eckert & Ziegler is currently unable to receive emails or phone calls. We understand the inconvenience this may cause and want to assure our ...

Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...

Ranked #1 in EHR & Digital Health Solutions by Black Book Research surveys of nearly 28,000 global EHR users-Leading Innovation Across All Spanish-Speaking Latin American Countries, Germany, Austria, ...

Gut-Brain Longevity Health Company bringing Patented Postbiotic for Functional Foods WINSTON-SALEM, NORTH CAROLINA / ACCESS Newswire / February 3, 2025 / Postbiotics, Inc., a longevity product ...

Cold Chain Technologies (CCT) and Tower Cold Chain, a subsidiary of CCT, have reached important milestones in their ongoing ...

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended an ...

Moberg Pharma AB (OMX: MOB) and Allderma today announce that the launch of Terclara® (MOB-015) is ongoing in Norway. The launch marks an important step in both companies' commercial strategy and ...

Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is part of Sanofi’s share buyback program announced on January 30, 2025. It is ...

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an ...

Biopsy Device MarketThe global biopsy device market is poised for steady, moderate growth in the coming decade, as outlined in a new study by Future Market Insights (FMI). The market, valued at an ...

Oxytocic Pharmaceuticals MarketThe global oxytocic pharmaceuticals market, valued at USD 114.58 million in 2023, is expected to experience robust growth, with projections indicating it will reach USD ...